Blog
Breakthrough Treatments

Breakthrough Treatments

Discover cutting-edge psychiatric treatments like TMS, psychedelics, and novel treatments. Learn about their research, clinical applications, and real-world impact.

Modern Solutions, Better Outcomes: A Psychiatrist's Guide to IV Ketamine

Entering Psychiatry's Golden Era with Dr. David Feifel, MD, PhD

New Real-World Evidence Supports Esketamine Nasal Spray as an Effective Treatment for Treatment-Resistant Depression

Comparative Effects of Esketamine and IV Ketamine for Major Depression: A Real-World Analysis

Evaluating TMS vs ECT vs Ketamine vs Esketamine

Streamline IV Ketamine Screening and Intake Documentation: A Guide for Clinicians

Safeguard Your Ketamine Clinic: Legal Expertise You Need to Know

Embracing Pragmatism for Ketamine Insurance Coverage: Leveraging Real-World Evidence

Data Without Distraction: Revolutionizing Vitals Monitoring During Ketamine Treatment

Autism, Ketamine, and Restorative Justice with Bergina Isbell, MD

Clinical Trials and Breakthrough Treatments with Michael Banov, MD

Can We Predict Ketamine Therapy Outcomes for Depression? This Model May Hold Promise

Community Spotlight: Propel Therapeutics, Defining High-Quality Ketamine Therapy

7 Predictions on Psychiatry's Future: Experts Weigh In

Stella’s Acquisition of Field Trip Health: A Pivotal Moment in Psychiatry

How to Write IV Ketamine Administration Notes (Template + Guide)

Shaping the Future of Psychedelic Treatments: Osmind's Response to FDA's Draft Guidance

Scaling innovative treatments: Dr. Tobias Marton's Journey from Psychiatry to Neuroscience to CMO of Mindful Health Solutions

Psychedelic Legal Frontiers: Preparing Practices for MDMA and Beyond with Husch Blackwell

Surprising Insights from Psychedelic Science 2023: Gul Dolen, Elias Dakwar, Michael Bogenschutz, and Karen Luong: Duration of experience, Psilocybin for Substance Abuse, and Legal Challenges

Osmind Announces Publication of Largest Real-World Study on Effectiveness of Ketamine Intravenous Therapy for Depression, Anxiety and Suicidal Ideation

Psychedelic Science 2023: Recommended Sessions to Attend

Unveiling the Future of TMS: Highlights from the Clinical TMS Society Annual Meeting

Set, Setting, and Unleashing the Healing Potential of Psychedelics with Andrew Penn, MS, PMHNP

How a CPT® Code Becomes “Real”: Implications for the New Psychedelic Medicine CPT® Codes

Transforming Mental Health in Unlikely Places: Denovo Therapy's Approach to Breaking Barriers and the Power of Journaling

The Comprehensive Guide to Integrating SPRAVATO® in Your Practice

Great Expectations: How do we know if psychedelics work? A deep-dive with Dr. Boris Heifets

Psychopharmacology of Psychedelics: What Every Psychiatrist Needs to Tell Their Patients on SSRIs with Dr. Kelan Thomas

Community Spotlight: Sonia Cotto of Ketamine and Wellness Clinic of South Florida

ACNP 2022 highlight: The Role of KORs in Mediating Stress-Related Deficits in Reward Processing: MOA of Ketamine and Aticaprant

The State of Innovative Mental Health Care pt.3: Future Predictions

The State of Innovative Mental Health Care pt. 2: How to Give Clinicians Their Time and Autonomy Back

Legal Considerations and Regulatory Updates for Psychedelic Medicine (2023)

The State of Innovative Mental Health Care pt. 1: Access to Care and Insurance Challenges

The Pivotal Role of Music in Ketamine and Psychedelic Treatments

Real-world evidence and ketamine infusion therapy: 2022 has been a good year

Accepting Credit Cards in Mental Health and Ketamine Practices: 10 Key Questions to Ask

Sublingual ketamine troches for home use: How clinicians can get started (part 2)

Community Spotlight: Ami Miller of Scenic City Neurotherapy

Sublingual ketamine troches for home use (Part 1): An evidence-based introduction

4 ways to empower ketamine infusion therapy patients with measurement-based care

Increasing patient engagement and retention during ketamine infusion therapy

The Evidence Base: News from the 2022 Ketamine and Related Compounds Conference

The Evidence Base: Two Ketamine Studies to Become Familiar with Now

Why your practice needs a mental health EHR, especially if you offer advanced intervention and treatment

Interventional Psychiatrists and Ketamine Clinicians: 5 Critical Questions for your Malpractice Insurance Carrier

A Patient’s Experience with Ketamine

Mental Health Support for First Responders

logo

Insights

AboutCareersBlogPodcastAffiliate

If you, or someone you know, is in crisis or needs immediate assistance, please call 911 immediately. To talk to someone now, please call the National Suicide Prevention Lifeline at 1-800-273-8255.

Osmind Inc. © 2024 All Rights Reserved.

Privacy Policy

Terms of Service